BSX Q1 2021 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena

BSXBoston Scientific Corporation

$105B

Q1 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$2.8B+8.2% YoY

Gross Profit

$1.7B60.6% margin

Operating Income

$360M13.1% margin

Net Income

$341M12.4% margin

EPS (Diluted)

$0.23

QoQ Revenue Growth

+1.6%

Cash Flow

Operating Cash Flow

$284M

Free Cash Flow

$209M

Stock-Based Comp.

$47M

Balance Sheet

Total Assets

$30.9B

Total Liabilities

$15.2B

Stockholders' Equity

$15.7B

Cash & Equivalents

$2.0B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.8B	$2.5B	+8.2%
Gross Profit	$1.7B	$1.5B	+10.2%
Operating Income	$360M	$223M	+61.4%
Net Income	$341M	$11M	+3000.0%

Revenue Segments

Cardiovascular

$1.1B41%

MedSurg

$860M31%

Cardiac Rhythm Management

$750M27%

Geographic Segments

UNITED STATES

$1.6B58%

Non-US

$1.2B42%